180
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Effect of mosquito mats (pyrethroid-based) vapor inhalation on rat brain cytochrome P450s

, , , , , & show all
Pages 41-46 | Received 22 Mar 2011, Accepted 23 May 2011, Published online: 14 Nov 2011

References

  • Alexidis AN, Commandeur JN, Rekka EA, Groot E. 1996. Novel piperidine derivatives: inhibitory properties towards cytochrome P450 isoforms and cytoprotective and cytotoxic characteristics. Environ Toxicol Pharm 27:81–88.
  • Anadón A, Martinez-Larrañaga MR, Fernandez-Cruz ML, Diaz MJ, Fernandez MC, Martinez MA. 1996. Toxicokinetics of deltamethrin and its 4′-HO-metabolite in the rat. Toxicol Appl Pharmacol 141:8–16.
  • Anand SS, Kim KB, Padilla S, Muralidhara S, Kim HJ, Fisher JW, Bruckner JV. 2006. Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: role in age-dependent acute neurotoxicity. Drug Metab Dispos 34:389–397.
  • Anandatheerthavarada HK, Shankar SK, Bhamre S, Boyd MR, Song BJ, Ravindranath V. 1993. Induction of brain cytochrome P-450IIE1 by chronic ethanol treatment. Brain Res 601:279–285.
  • Bebe FN, Panemangalore M. 2005. Pesticides and essential minerals modify endogenous antioxidants and cytochrome P450 in tissues of rats. J Environ Sci Health B 40:769–784.
  • Bradberry SM, Cage SA, Proudfoot AT, Vale JA. 2005. Poisoning due to pyrethroids. Toxicol Rev 24:93–106.
  • Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. 1985. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34:3337–3345.
  • Burke MD, Thompson S, Weaver RJ, Wolf CR, Mayer RT. 1994. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 48:923–936.
  • Cederbaum AI, Wu D, Mari M, Bai J. 2001. CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic Biol Med 31:1539–1543.
  • Das RK, Sahu K, Dash BC. 1994. Induction of chromosome aberrations and micronuclei in pulmonary alveolar macrophages of rats following inhalation of mosquito coil smoke. Mutat Res 320:285–292.
  • de Waziers I, Cugnenc PH, Yang CS, Leroux JP, Beaune PH. 1990. Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253:387–394.
  • Ding X, Kaminsky LS. 2003. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149–173.
  • Godin SJ, Scollon EJ, Hughes MF, Potter PM, DeVito MJ, Ross MK. 2006. Species differences in the in vitro metabolism of deltamethrin and esfenvalerate: differential oxidative and hydrolytic metabolism by humans and rats. Drug Metab Dispos 34:1764–1771.
  • Guengerich FP, Shimada T. 1991. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4:391–407.
  • Guengerich FP. 1995. Influence of nutrients and other dietary materials on cytochrome P-450 enzymes. Am J Clin Nutr 61:651S–658S.
  • Guengerich FP. 2001. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14:611–650.
  • Haorah J, Ramirez SH, Floreani N, Gorantla S, Morsey B, Persidsky Y. 2008. Mechanism of alcohol-induced oxidative stress and neuronal injury. Free Radic Biol Med 45:1542–1550.
  • Hernández-Martínez N, Caballero-Ortega H, Dorado-González V, Labra-Ruiz N, Espinosa-Aguirre JJ, Gómez-Garduño J, Vences-Mejía A. 2007. Tissue-specific induction of the carcinogen-inducible cytochrome P450 isoforms in the gastrointestinal tract. Environ Toxicol Pharm 24:297–303.
  • Hollenberg PF. 2002. Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug Metab Rev 34:17–35.
  • Johri A, Dhawan A, Lakhan Singh R, Parmar D. 2006. Effect of prenatal exposure of deltamethrin on the ontogeny of xenobiotic metabolizing cytochrome P450s in the brain and liver of offsprings. Toxicol Appl Pharmacol 214:279–289.
  • Kapoor N, Pant AB, Dhawan A, Dwievedi UN, Seth PK, Parmar D. 2007. Differences in the expression and inducibility of cytochrome P450 2B isoenzymes in cultured rat brain neuronal and glial cells. Mol Cell Biochem 305:199–207.
  • Kolars JC, Schmiedlin-Ren P, Dobbins WO 3rd, Schuetz J, Wrighton SA, Watkins PB. 1992. Heterogeneity of cytochrome P450IIIA expression in rat gut epithelia. Gastroenterology 102:1186–1198.
  • Koop DR. 1986. Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Mol Pharmacol 29:399–404.
  • Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685.
  • Lieber CS. 1997. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77:517–544.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
  • Manna S, Bhattacharyya D, Mandal TK, Das S. 2004. Repeated dose toxicity of alfa-cypermethrin in rats. J Vet Sci 5:241–245.
  • Maron DM, Ames BN. 1983. Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173–215.
  • Meyer RP, Gehlhaus M, Knoth R, Volk B. 2007. Expression and function of cytochrome p450 in brain drug metabolism. Curr Drug Metab 8:297–306.
  • Nissbrandt H, Bergquist F, Jonason J, Engberg G. 2001. Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway? Synapse 40:294–301.
  • Novak RF, Woodcroft KJ. 2000. The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression. Arch Pharm Res 23:267–282.
  • Osimitz TG, Sommers N, Kingston R. 2009. Human exposure to insecticide products containing pyrethrins and piperonyl butoxide (2001-2003). Food Chem Toxicol 47:1406–1415.
  • Parmar D, Yadav S, Dayal M, Johri A, Dhawan A, Seth PK. 2003. Effect of lindane on hepatic and brain cytochrome P450s and influence of P450 modulation in lindane induced neurotoxicity. Food Chem Toxicol 41:1077–1087.
  • Pavek P, Dvorak Z. 2008. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab 9:129–143.
  • Price RJ, Giddings AM, Scott MP, Walters DG, Capen CC, Osimitz TG, Lake BG. 2008. Effect of Pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes. Toxicology 243:84–95.
  • Rendic S. 2002. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 34:83–448.
  • Rickard J, Brodie ME. 1985. Correlation of blood and brain levels of the neurotoxic pyrethroid deltamethrin with the onset of symptoms in rats. Pestic Biochem Physiol 23:143–156.
  • Schilter B, Andersen MR, Acharya C, Omiecinski CJ. 2000. Activation of cytochrome P450 gene expression in the rat brain by phenobarbital-like inducers. J Pharmacol Exp Ther 294:916–922.
  • Scollon EJ, Starr JM, Godin SJ, DeVito MJ, Hughes MF. 2009. In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome p450 isoforms. Drug Metab Dispos 37:221–228.
  • Singh S, Singh K, Patel S, Patel DK, Singh C, Nath C, Singh MP. 2008. Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s disease phenotype in mouse. Brain Res 1207:193–206.
  • Soderlund DM, Clark JM, Sheets LP, Mullin LS, Piccirillo VJ, Sargent D, Stevens JT, Weiner ML. 2002. Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. Toxicology 171:3–59.
  • Strobel HW, Geng J, Kawashima H, Wang H. 1997. Cytochrome P450-dependent biotransformation of drugs and other xenobiotic substrates in neural tissue. Drug Metab Rev 29:1079–1105.
  • Tiwari MN, Singh AK, Ahmad I, Upadhyay G, Singh D, Patel DK, Singh C, Prakash O, Singh MP. 2010. Effects of cypermethrin on monoamine transporters, xenobiotic metabolizing enzymes and lipid peroxidation in the rat nigrostriatal system. Free Radic Res 44:1416–1424.
  • Vences-Mejía A, Labra-Ruíz N, Hernández-Martínez N, Dorado-González V, Gómez-Garduño J, Pérez-López I, Nosti-Palacios R, Camacho Carranza R, Espinosa-Aguirre JJ. 2006. The effect of aspartame on rat brain xenobiotic-metabolizing enzymes. Hum Exp Toxicol 25:453–459.
  • Wolansky MJ, Gennings C, Crofton KM. 2006. Relative potencies for acute effects of pyrethroids on motor function in rats. Toxicol Sci 89:271–277.
  • Wolansky MJ, Gennings C, DeVito MJ, Crofton KM. 2009. Evidence for dose-additive effects of pyrethroids on motor activity in rats. Environ Health Perspect 117:1563–1570.
  • Yadav S, Johri A, Dhawan A, Seth PK, Parmar D. 2006. Regional specificity in deltamethrin induced cytochrome P450 expression in rat brain. Toxicol Appl Pharmacol 217:15–24.
  • Yang D, Wang X, Chen YT, Deng R, Yan B. 2009. Pyrethroid insecticides: isoform-dependent hydrolysis, induction of cytochrome P450 3A4 and evidence on the involvement of the pregnane X receptor. Toxicol Appl Pharmacol 237:49–58.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.